Home / Netherlands / Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV
No short position is open on this share today.
Evolution of the disclosed total
July 31, 2015 today
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on Lakefront Biotherapeutics NV by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 21, 2020 | Citadel Advisors LLC | 0.50% | |
| July 20, 2020 | Citadel Advisors LLC | 0.49% | |
| July 13, 2020 | D. E. Shaw & Co., L.P. | 0.79% | |
| July 10, 2020 | D. E. Shaw & Co., L.P. | 0.80% | |
| July 9, 2020 | D. E. Shaw & Co., L.P. | 0.79% | |
| June 24, 2020 | Citadel Advisors LLC | 0.50% | |
| June 11, 2020 | Marshall Wace LLP | 0.82% | |
| June 2, 2020 | Marshall Wace LLP | 0.72% | |
| May 21, 2020 | Marshall Wace LLP | 0.69% | |
| May 18, 2020 | Marshall Wace LLP | 0.57% | |
| May 13, 2020 | Marshall Wace LLP | 0.68% | |
| May 11, 2020 | D. E. Shaw & Co., L.P. | 0.89% | |
| May 8, 2020 | Marshall Wace LLP | 0.71% | |
| April 29, 2020 | Marshall Wace LLP | 0.69% | |
| April 21, 2020 | Numeric Investors LLC | 0.47% | |
| April 16, 2020 | Marshall Wace LLP | 0.73% | |
| April 15, 2020 | D. E. Shaw & Co., L.P. | 0.99% | |
| April 15, 2020 | Marshall Wace LLP | 0.69% | |
| April 7, 2020 | D. E. Shaw & Co., L.P. | 1.00% | |
| April 7, 2020 | Marshall Wace LLP | 0.73% | |
| April 7, 2020 | Numeric Investors LLC | 0.51% | |
| April 6, 2020 | Marshall Wace LLP | 0.69% | |
| March 27, 2020 | Numeric Investors LLC | 0.49% | |
| March 26, 2020 | Marshall Wace LLP | 0.78% | |
| March 24, 2020 | Numeric Investors LLC | 0.59% | |
| March 23, 2020 | Marshall Wace LLP | 0.84% | |
| March 20, 2020 | Marshall Wace LLP | 0.90% | |
| March 20, 2020 | Citadel Advisors LLC | 0.45% | |
| March 19, 2020 | Marshall Wace LLP | 1.04% | |
| March 19, 2020 | Numeric Investors LLC | 0.69% | |
| March 18, 2020 | Citadel Advisors LLC | 0.57% | |
| March 17, 2020 | Marshall Wace LLP | 1.25% | |
| March 17, 2020 | D. E. Shaw & Co., L.P. | 0.90% | |
| March 17, 2020 | Numeric Investors LLC | 0.71% | |
| March 16, 2020 | Citadel Advisors LLC | 0.69% | |
| March 12, 2020 | Marshall Wace LLP | 1.39% | |
| March 12, 2020 | D. E. Shaw & Co., L.P. | 0.87% | |
| March 12, 2020 | Numeric Investors LLC | 0.53% | |
| March 11, 2020 | Marshall Wace LLP | 1.40% | |
| March 10, 2020 | Marshall Wace LLP | 1.38% | |
| March 9, 2020 | Marshall Wace LLP | 1.40% | |
| March 9, 2020 | D. E. Shaw & Co., L.P. | 0.96% | |
| March 3, 2020 | D. E. Shaw & Co., L.P. | 1.04% | |
| March 2, 2020 | Marshall Wace LLP | 1.30% | |
| February 28, 2020 | Marshall Wace LLP | 1.29% | |
| February 28, 2020 | D. E. Shaw & Co., L.P. | 0.96% | |
| February 27, 2020 | Citadel Advisors LLC | 0.79% | |
| February 26, 2020 | Marshall Wace LLP | 1.31% | |
| February 26, 2020 | Citadel Advisors LLC | 0.88% | |
| February 25, 2020 | Numeric Investors LLC | 0.39% |
Download 689 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the Netherlands
- Akzo Nobel N.V. 9.86% of the capital sold short
- Pharming Group N.V. 7.95% of the capital sold short
- Signify N.V. 7.52% of the capital sold short
- Imcd N.V. 4.65% of the capital sold short
- Fugro N.V. 4.20% of the capital sold short
- DSM-Firmenich AG 3.48% of the capital sold short
- Basic-Fit N.V. 3.43% of the capital sold short
- PostNL N.V. 2.55% of the capital sold short
- NSI N.V. 2.01% of the capital sold short
- Alfen N.V. 1.85% of the capital sold short
- Arcadis N.V. 1.72% of the capital sold short
- Sligro Food Group N.V. 1.55% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv?page=6